Beximco Pharmaceuticals Ltd has contradicted a news item, published in the media on Saturday that Eskayef was the first company to produce Remdesivir in the country wherein it was mentioned that the company initiated distributing preparations from Friday.
"We believe the story is factually incorrect. We would like to clarify that Beximco Pharma not only was first company in Bangladesh to produce this drug but also the only company which has submitted final product samples to drug regulatory authority, Directorate General of Drug Administration (DGDA), for testing and approval. After producing this generic drug and successfully conducting all necessary tests in house we submitted final product samples to DGDA on 7th May 2020, for testing and approval," Beximco Pharmaceuticals said in a statement.
"This is a mandatory legal requirement which must be complied with before any company can distribute any drug in Bangladesh or globally. Beximco Pharma refrained from announcing that it has produced the drug because it felt doing so without being validated by the regulatory body would have been irresponsible and unethical and would have misled the public."
"We are releasing this Press Note in greater public interest to clarify the matter and dispel any confusion that may have been caused by the above-mentioned news items," Beximco Pharma said.
-rmc/